1
项与 LGT (TP21)/DEN4(NIAID) 相关的临床试验Phase 1 Study of the Safety and Immunogenicity of Tick-Borne Langat/Dengue 4 Chimera (LGT(TP21)/DEN4), a Live Attenuated Vaccine for Tick-Borne Encephalitis
Tick-borne encephalitis (TBE) is a viral illness common in the Northern Hemisphere, especially Europe and Asia. TBE infection may lead to central nervous system problems and death. The purpose of this study is to test the safety of and immune response to a TBE vaccine in healthy adults. The vaccine is related to a live attenuated virus developed against dengue virus infection.
100 项与 LGT (TP21)/DEN4(NIAID) 相关的临床结果
100 项与 LGT (TP21)/DEN4(NIAID) 相关的转化医学
100 项与 LGT (TP21)/DEN4(NIAID) 相关的专利(医药)
100 项与 LGT (TP21)/DEN4(NIAID) 相关的药物交易